Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
The drug development industry is moving faster than ever, and timelines are continuing to shorten across parts of the process. AI is increasingly being applied
Ask any clinical operations leader where study startup time disappears, and the answer rarely points to a single dramatic failure. More often, the culprit is
Clinical trials generate enormous amounts of data. For decades, the industry has relied on a familiar approach to keep that data clean through rules, edit
The period immediately following Data Base Lock (DBL) is often the most stressful window in a clinical trial. While the “hard work” of data collection
According to the Tufts Center for the Study of Drug Development, the average clinical trial can take 7–10 years from discovery to approval, and delays
Clinical data review has always been one of those parts of a trial that takes more time than anyone expects. An industry report by NIH
If your company is experimenting with AI, here’s a statistic worth pausing on. Recent MIT research says “95% of AI initiatives fail to show real
The pharmaceutical industry has cracked some of its toughest challenges, from shortening trial timelines to improving patient recruitment and building sophisticated data platforms. Yet one
When racing to develop a COVID-19 vaccine, a top 20 pharmaceutical company partnered with Saama to tackle one of the most critical milestones in clinical
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.
